Irene Eriksson

TL;DR: The numerous applications of drug utilization research are illustrated in Part 3, which include sections on comparative drug utilizationResearch, drug utilization and health policy, and the assessment and improvement of the quality of medicine use.

TL;DR: The objective is to review case histories among health authorities to improve the utilization and expenditure on new medicines, as well as develop exemplar models for valuing medicines for orphan diseases alongside potentially capping pharmaceutical expenditure.

TL;DR: Drug Utilization Research is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes.

TL;DR: Development of a new model and future guidance is proposed to better manage the entry of new drugs, centering on three pillars of pre-, peri-, and post-launch activities.

TL;DR: Concerns and potential ways forward are discussed and a number of recommendations are presented from the perspective of payers about the concept of MAPPs and possible challenges.